Company
Headquarters: Snailwell, United Kingdom
Employees: 196
CEO: Mr. Paul C. Swinney
£219.6 Million
GBP as of July 1, 2024
US$277.8 Million
Company | Market Cap (USD) |
---|---|
Intuitive | $154.23 B |
EssilorLuxottica SA | $98.99 B |
Becton, Dickinson and Company | $65.82 B |
Alcon Inc. | $43.72 B |
HOYA Corp | $42.76 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand; contamination control products, which include cleanroom, laboratory, pharmaceutical, cosmetic, and toiletry disinfectants under the Crystel brand; and airborne and veterinary device disinfectants under the Anistel brand. The company was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Tristel plc has the following listings and related stock indices.
Stock: LSE: TSTL wb_incandescent
Stock: FSX: R1V wb_incandescent